CytoDyn and Philippine Airlines Work Together to Provide
VANCOUVER, Wash., June 01, 2021 (GLOBE NEWSWIRE) - CytoDyn Inc. (OTC.QB: CYDY), ("CytoDyn" or the "Firm"), a late-stage biotechnology firm growing Vyrologix ™ (Leronlimab), a CCR5 antagonist with doubtlessly a number of therapeutic…